Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma Bo Xu Review 21 January 2022 Pages: 707 - 719
The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials Mohammad Mehdi MohammadiRoghayeh MirjaliliAzam Faraji Review 21 January 2022 Pages: 721 - 731
Safety profile of COVID-19 drugs in a real clinical setting Mei Nee ChiuMaitry BhardwajSangeeta Pilkhwal Sah Review 28 January 2022 Pages: 733 - 753
Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? a systematic review and meta-analysis Eslam Mohammed RabeaKirellos Said AbbasBasel Abdelazeem Review 18 February 2022 Pages: 755 - 763
Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review Simone SkullbackaMarja AiraksinenTerhi Toivo Review Open access 14 February 2022 Pages: 765 - 779
Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus Ar Kar AungSteven WalkerLinda Velta Graudins Review Open access 16 February 2022 Pages: 781 - 791
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study Ziwan GuanYue DuYan Li Clinical Trial 25 January 2022 Pages: 793 - 799
The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study Fabian MüllerMichael SandJürgen M. Steinacker Clinical Trial Open access 28 January 2022 Pages: 801 - 812
Low-dose lidocaine attenuates fentanyl-induced cough: A double-blind randomized controlled trial Nuanwan PhuvachoterojanaphokinGrit WatanaboonyongcharoenSithapan Munjupong Clinical Trial 28 January 2022 Pages: 813 - 821
Investigation of pharmacokinetic and clinical outcomes of various meropenem regimens in patients with ventilator-associated pneumonia and augmented renal clearance Sareh RazzazzadehIlad Alavi DarazamZahra Sahraei Pharmacodynamics 16 February 2022 Pages: 823 - 829
Population pharmacokinetic and dose optimization of mycophenolic acid in children with anti-neutrophilic cytoplasmic antibody-associated nephritis Ziwei LiYidie HuangZhiping Li Pharmacokinetics and Disposition 22 January 2022 Pages: 831 - 838
Assessing the binding interaction of polystyrene sulfonate with amitriptyline in healthy volunteers: a cross-over design — The BIND study I. Prins - CanI. R. F. van Berlo - van de LaarF. G. A. Jansman Pharmacokinetics and Disposition 16 February 2022 Pages: 839 - 845
Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study Vorawee VaravithyaChayanee TirapatPasitpon Vatcharavongvan Pharmacoepidemiology and Prescription 29 January 2022 Pages: 847 - 855
Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol Elisabeth PedersenRaul PrimicerioMarit Waaseth Pharmacoepidemiology and Prescription Open access 21 January 2022 Pages: 857 - 867
Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study Helena NorbergMaria SjölanderMaria Gustafsson Pharmacoepidemiology and Prescription Open access 14 February 2022 Pages: 869 - 877
Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation Andreina CarboneFrancesco SantelliVincenzo Russo Pharmacoepidemiology and Prescription Open access 09 February 2022 Pages: 879 - 886
Drug-induced hypohidrosis and anhidrosis: analysis of the WHO pharmacovigilance database 2000–2020 Jean-Louis MontastrucGeneviève Durrieu Letter to the Editor 30 January 2022 Pages: 887 - 889
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report Stefania CheliValeria CozziChiara Moretti Letter to the Editor 18 February 2022 Pages: 891 - 893
Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis Massimo TempestilliGiulia Valeria StaziChiara Agrati Correction 03 March 2022 Pages: 895 - 895
